drugset / Trial / NCT06017362

Clinical Trial to Determine the Efficacy and Safety of Insulin Eye Drops in Dry Eye in Patients with Topical Hypotensors

NCT06017362

Phase 4 Recruiting 100 enrolled Barbara Burgos Blasco
RandomizedParallel-groupSingle-blindTreatment

Summary

The goal of this clinical trial is to evaluate the preliminary efficacy of the use of insulin eye drops in the control of dry eye disease in patients with topical hypotensors, compared to placebo (artificial tears). The main question aims to answer whether glaucoma patients treated with topical hypotensors could benefit from the use of insulin eye drops for the treatment of dry eye. Participants will be assigned to one of the two treatment arms and will be required to attend four follow-up visits (baseline, 1, 3, and 6 months).

Timeline

Start
2023-02-08
Primary completion
2026-02-08
Completion
2026-02-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic 1 iu Topical